ALTEROLA BIOTECH INC. Quarterly Return On Equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alterola Biotech Inc. quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q2 2024.
  • Alterola Biotech Inc. Return On Equity for the quarter ending June 30, 2024 was 151 %.
  • Alterola Biotech Inc. annual Return On Equity for 2023 was -7.31 %, a 92.6% increase from 2022.
  • Alterola Biotech Inc. annual Return On Equity for 2022 was -98.9 %, a 339% decline from 2021.
  • Alterola Biotech Inc. annual Return On Equity for 2021 was 41.5 %, a 71.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 151 +157 Apr 1, 2024 Jun 30, 2024
Q1 2024 -174 -168 -2628% Jan 1, 2024 Mar 31, 2024
Q4 2023 -11.2 +63.4 +85% Oct 1, 2023 Dec 31, 2023
Q3 2023 -5.01 +123 +96.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -5.3 +195 +97.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -6.38 +450 +98.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.6 -505 -117% Oct 1, 2022 Dec 31, 2022
Q3 2022 -128 -241 -214% Jul 1, 2022 Sep 30, 2022
Q2 2022 -200 Apr 1, 2022 Jun 30, 2022
Q1 2022 -456 Jan 1, 2022 Mar 31, 2022
Q4 2021 430 Oct 1, 2021 Dec 31, 2021
Q3 2021 113 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.